ONLINE DATABASE SEARCH - HIV-LS-326-MEMO
1. 47600 HIV-LS-326; PUBMED-HIV-7/11/2005
Synthesis and Biological Evaluation of Geminal Disulfones as HIV-1 Integrase Inhibitors
Meadows, DC, Mathews, TB, North, TW, Hadd, MJ, Kuo, CL, Neamati, N, and Gervay-Hague, J
J Med Chem 2005. 48(14): 4526-4534
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15999991&dopt=abstract
2. 47601 HIV-LS-326; PUBMED-HIV-7/11/2005
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4
Zhao, Q, Ma, L, Jiang, S, Lu, H, Liu, S, He, Y, Strick, N, Neamati, N, and Debnath, AK
Virology 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15996703&dopt=abstract
3. 47602 HIV-LS-326; EMBASE-HIV-7/11/2005
The anti-HIV-1 effect of scutellarin
Zhang, Gao-Hong, Wang, Qian, Chen, Ji-Jun, Zhang, Xue-Mei, Tam, Siu-Cheung, and Zheng, Yong-Tang
Biochemical and Biophysical Research Communications 2005. In Press, Uncorrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WBK-4GKWC17-6/2/be21d9d7c2f71c1c5c7c8de22a1160e5
4. 47603 HIV-LS-326; PUBMED-HIV-7/11/2005
Synthesis of 6-(3,5-Dichlorobenzyl) Derivatives as Isosteric Analogues of the HIV Drug 6-(3,5-Dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil (GCA-186)
Sorensen, ER, El-Brollosy, NR, Jorgensen, PT, Pedersen, EB, and Nielsen, C
Arch Pharm (Weinheim) 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15996003&dopt=abstract
5. 47604 HIV-LS-326; EMBASE-HIV-7/11/2005
HIV chemokine receptor inhibitors as novel anti-HIV drugs
Princen, Katrien and Schols, Dominique
Cytokine & Growth Factor Reviews 2005. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T5V-4GJVBG7-1/2/7a08787d0807434f9f47e45cfaa13c4b
6. 47605 HIV-LS-326; PUBMED-HIV-7/11/2005
Structure-based design, synthesis, and in vitro assay of novel nucleoside analog inhibitors against HIV-1 reverse transcriptase
Liu, X, Xie, W, and Huang, RH
Bioorg Med Chem Lett 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15993595&dopt=abstract
7. 47606 HIV-LS-326; PUBMED-HIV-7/11/2005
Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles
Miller, JF, Brieger, M, Furfine, ES, Hazen, RJ, Kaldor, I, Reynolds, D, Sherrill, RG, and Spaltenstein, A
Bioorg Med Chem Lett 2005. 15(15): 3496-500
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15990305&dopt=abstract
8. 47607 HIV-LS-326; PUBMED-HIV-7/11/2005
Synthesis and biological evaluation of new N-substituted-N'-(3,5-di/1,3,5-trimethylpyrazole-4-yl)thiourea/urea derivatives
Kaymakcioglu, BK, Rollas, S, Korcegez, E, and Aricioglu, F
Eur J Pharm Sci 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15990284&dopt=abstract
9. 47608 HIV-LS-326; PUBMED-HIV-7/11/2005
Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors
Andreola, ML, Nguyen, CH, Ventura, M, Tarrago-Litvak, L, and Legraverend, M
Expert Opin Emerg Drugs 2001. 6(2): 225-238
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15989523&dopt=abstract
10. 47609 HIV-LS-326; EMBASE-HIV-7/11/2005
Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA)
Polianova, Maria T, Ruscetti, Francis W, Pert, Candace B, and Ruff, Michael R
Antiviral Research 2005. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4GDSCC8-1/2/d5d363c1b8e90b0b0b3db65273be8a64
11. 47610 HIV-LS-326; PUBMED-HIV-7/11/2005
Interaction of silver nanoparticles with HIV-1
Elechiguerra, JL, Burt, JL, Morones, JR, Camacho-Bragado, A, Gao, X, Lara, HH, and Jose, Yacaman M
J Nanobiotechnology 2005. 3(1): 6
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15987516&dopt=abstract
12. 47611 HIV-LS-326; PUBMED-HIV-7/11/2005
Biyouyanagin A, an Anti-HIV Agent from Hypericum chinense L. var. salicifolium
Tanaka, N, Okasaka, M, Ishimaru, Y, Takaishi, Y, Sato, M, Okamoto, M, Oshikawa, T, Ahmed, SU, Consentino, LM, and Lee, KH
Org Lett 2005. 7(14): 2997-2999
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15987189&dopt=abstract
13. 47612 HIV-LS-326; EMBASE-HIV-7/11/2005
Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry
Colombo, S, Beguin, A, Telenti, A, Biollaz, J, Buclin, T, Rochat, B, and Decosterd, LA
Journal of Chromatography B 2005. 819(2): 259-276
HYPERLINK:
http://www.sciencedirect.com/science/article/B6X0P-4FVCBT9-1/2/927c6044c4faca73d227467f2a121d47
14. 47613 HIV-LS-326; PUBMED-HIV-7/11/2005
Safety, pharmacokinetics, and efficacy of (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine with efavirenz and stavudine in antiretroviral-naive human immunodeficiency virus-infected patients
Herzmann, C, Arasteh, K, Murphy, RL, Schulbin, H, Kreckel, P, Drauz, D, Schinazi, RF, Beard, A, Cartee, L, and Otto, MJ
Antimicrob Agents Chemother 2005. 49(7): 2828-33
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15980356&dopt=abstract
15. 47614 HIV-LS-326; PUBMED-HIV-7/11/2005
Pharmacology and pharmacokinetics of the antiviral agent beta-D-2',3'-dideoxy-3'-oxa-5-fluorocytidine in cells and rhesus monkeys
Hernandez-Santiago, BI, Chen, H, Asif, G, Beltran, T, Mao, S, Hurwitz, SJ, Grier, J, McClure, HM, Chu, CK, Liotta, DC, and Schinazi, RF
Antimicrob Agents Chemother 2005. 49(7): 2589-97
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15980324&dopt=abstract
16. 47615 HIV-LS-326; PUBMED-HIV-7/11/2005
Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs
Vermeire, K and Schols, D
J Antimicrob Chemother 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15980096&dopt=abstract
17. 47616 HIV-LS-326; PUBMED-HIV-7/11/2005
Anti-HIV properties of cationic fullerene derivatives
Marchesan, S, Da Ros, T, Spalluto, G, Balzarini, J, and Prato, M
Bioorg Med Chem Lett 2005. 15(15): 3615-3618
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15978810&dopt=abstract
18. 47617 HIV-LS-326; EMBASE-HIV-7/11/2005
The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs
Auwerx, Joeri, Van Nieuwenhove, Joke, Rodriguez-Barrios, Fatima, de Castro, Sonia, Velazquez, Sonsoles, Ceccherini-Silberstein, Francesca, De Clercq, Erik, Camarasa, Maria-Jose, Perno, Carlo-Federico, Gago, Federico, and Balzarini, Jan
FEBS Letters 2005. 579(11): 2294-2300
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T36-4FSNV90-3/2/ea23d92714192e5279f5b34e4348deab
19. 47618 HIV-LS-326; PUBMED-HIV-7/11/2005
CCR5 N-terminal region plays a critical role in HIV-1 inhibition by toxoplasma gondii derived cyclophilin-18
Golding, H, Khurana, S, Yarovinsky, F, King, LR, Abdoulaeva, G, Antonsson, L, Owman, C, Platt, EJ, Kabat, D, Andersen, JF, and Sher, A
J Biol Chem 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15975927&dopt=abstract
20. 47619 HIV-LS-326; PUBMED-HIV-7/11/2005
Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography
Hirabayashi, Y, Tsuchiya, K, Kimura, S, and Oka, S
Biomed Chromatogr 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15971289&dopt=abstract
21. 47620 HIV-LS-326; PUBMED-HIV-7/11/2005
Role of T139 in the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitivity to (+)-calanolide A
Auwerx, J, Rodriguez-Barrios, F, Ceccherini-Silberstein, F, San-Felix, A, Velazquez, S, De, Clercq E, Camarasa, MJ, Perno, CF, Gago, F, and Balzarini, J
Mol Pharmacol 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15961674&dopt=abstract
22. 47621 HIV-LS-326; WOS-HIV-7/3/2005
Antiretroviral compounds: Mechanisms underlying failure of HAART to eradicate HIV-1
Shehu-Xhilaga, M, Tachedjian, G, Crowe, SM, and Kedzierska, K
CURRENT MEDICINAL CHEMISTRY 2005. 12(15): 1705-1719, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000229763600001
23. 47622 HIV-LS-326; WOS-HIV-7/3/2005
Synthesis of 2-(aminocarbonylmethylthio)-1H-imidazoles as novel Capravirine analogues
Loksha, YM, El-Barbary, AA, El-Badawi, MA, Nielsen, C, and Pedersen, EB
BIOORGANIC & MEDICINAL CHEMISTRY 2005. 13(13): 4209-4220, 12
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000229811900009
24. 47623 HIV-LS-326; WOS-HIV-7/10/2005
The molecular mechanism of human resistance to HIV-1 infection in persistently infected individuals - A review, hypothesis and implications
Becker, Y
VIRUS GENES 2005. 31(1): 113-120, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000229908000014
25. 47624 HIV-LS-326; WOS-HIV-7/10/2005
Isolation and characterization of the ALP1 protease from Aspergillus fumigatus and its protein inhibitor from Physarium polycephalum
Davies, DA, Kalinina, NA, Samokhvalova, LV, Malakhova, GV, Scott, G, Venning, G, Volynskaya, AM, and Nesmeyanov, VA
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2005. 31(3): 229-237, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000230025700007
26. 47625 HIV-LS-326; WOS-HIV-7/10/2005
Sesquiterpenes and butenolides, natural anti-HIV constituents from Litsea verticillata
Zhang, HJ, Van Hung, N, Cuong, NM, Soejarto, DD, Pezzuto, JM, Fong, HHS, and Tan, GT
PLANTA MEDICA 2005. 71(5): 452-457
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000229864200013
27. 47626 HIV-LS-326; WOS-HIV-7/10/2005
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life
Kovacs, A, Cowles, MK, Britto, P, Capparelli, E, Fowler, MG, Moye, J, McIntosh, K, Rathore, MH, Pitt, J, and Husson, RN
PEDIATRIC INFECTIOUS DISEASE JOURNAL 2005. 24(6): 503-509, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000230042900005
28. 47627 HIV-LS-326; WOS-HIV-7/10/2005
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection
Campbell, TB, Shulman, NS, Johnson, SC, Zolopa, AR, Young, RK, Bushman, L, Fletcher, CV, Lanier, ER, Merigan, TC, and Kuritzkes, DR
CLINICAL INFECTIOUS DISEASES 2005. 41(2): 236-242, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000229890800016